We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZEK
101
DELISTED
The AZEK Co
AZEK
$1.92M 0.23%
40,979
+19,835
+94% +$850K
POWI icon
102
Power Integrations
POWI
$3.53B
$1.92M 0.23%
29,891
+8,496
+40% +$561K
ODFL icon
103
Old Dominion Freight Line
ODFL
$47.2B
$1.91M 0.23%
+9,610
New +$1.87M
BPOP icon
104
Popular Inc
BPOP
$10.9B
$1.88M 0.22%
18,752
+16,244
+648% +$1.58M
CRDO icon
105
Credo Technology Group
CRDO
$38.8B
$1.87M 0.22%
60,805
+33,051
+119% +$985K
ZIM icon
106
ZIM Integrated Shipping Services
ZIM
$2.96B
$1.87M 0.22%
+72,937
New +$1.42M
DOLE icon
107
Dole
DOLE
$1.34B
$1.82M 0.22%
111,915
+95,225
+571% +$1.42M
HOOD icon
108
Robinhood
HOOD
$85.9B
$1.82M 0.22%
+77,772
New +$1.64M
PSMT icon
109
Pricesmart
PSMT
$5.81B
$1.8M 0.22%
19,642
+2,016
+11% +$174K
RXST icon
110
RxSight
RXST
$233M
$1.8M 0.22%
36,423
+8,471
+30% +$434K
MGY icon
111
Magnolia Oil & Gas
MGY
$5.53B
$1.8M 0.21%
+73,555
New +$1.85M
MA icon
112
Mastercard
MA
$487B
$1.77M 0.21%
3,587
+1,509
+73% +$702K
CRBG icon
113
Corebridge Financial
CRBG
$14.3B
$1.77M 0.21%
60,717
+34,788
+134% +$984K
GAP
114
The Gap Inc
GAP
$7.07B
$1.76M 0.21%
+80,019
New +$1.78M
NBIX icon
115
Neurocrine Biosciences
NBIX
$17.7B
$1.75M 0.21%
15,227
+1,578
+12% +$216K
IPG
116
DELISTED
Interpublic Group of Companies
IPG
$1.75M 0.21%
+55,443
New +$1.7M
UNH icon
117
UnitedHealth
UNH
$379B
$1.75M 0.21%
2,993
-1,150
-28% -$650K
VLO icon
118
Valero Energy
VLO
$90.5B
$1.74M 0.21%
+12,915
New +$1.88M
BKNG icon
119
Booking.com
BKNG
$145B
$1.73M 0.21%
+10,250
New +$1.57M
AMBA icon
120
Ambarella
AMBA
$2.99B
$1.72M 0.21%
30,535
+16,050
+111% +$854K
BAM icon
121
Brookfield Asset Management
BAM
$75.9B
$1.71M 0.21%
+36,241
New +$1.52M
CNI icon
122
Canadian National Railway
CNI
$78B
$1.71M 0.2%
+14,611
New +$1.7M
HRL icon
123
Hormel Foods
HRL
$14.3B
$1.71M 0.2%
53,936
+45,389
+531% +$1.44M
FSS icon
124
Federal Signal
FSS
$7.22B
$1.7M 0.2%
+18,224
New +$1.67M
MQ icon
125
Marqeta
MQ
$1.85B
$1.69M 0.2%
85,625
+5,952
+7% +$125K
3 4
5
6 7

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.